BioSpace News Archive

Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures

Expansion of management team continues with addition of an industry leader with deep experience in business development, licensing, and strategy in the life-science industry

TRACON Pharmaceuticals announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview at the Jefferies Virtual Healthcare Conference on June 4, 2021 at 2:30pm Eastern Time.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that the company will host a conference call and webcast to review initial data from the ongoing Phase 1b study of ORIC-101, a glucocorticoid receptor antagonist, in combination with nab-paclitaxel in advanced solid tumors.

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, announced that it has elucidated the mechanism of action of Adva-27a, the Company’s flagship anticancer drug candidate.

Avadel Pharmaceuticals plc, a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat on Tuesday, June 1 at 9:00 a.m. ET.

Inovytec, a developer of medical devices that address emergency and routine respiratory and cardiac care, announced that it has been recognized by the 2021 Smart 50 Awards for the implementation of SALI, a clinically proven, smart critical aid system that enables bystanders to provide treatment to people experiencing a medical emergency.

Eclipse Bioinnovations, a leading RNA genomics company offering technology solutions that accelerate RNA research, will be presenting four scientific posters and a webinar at the RNA Society 2021 annual meeting to be held virtually May 25 through June 4, 2021.

Tavanta Therapeutics, a specialty pharmaceutical company, announced that the first patient has been dosed in a recently initiated global Phase 3 clinical trial evaluating TAVT-45 Granules for oral suspension, a novel and proprietary formulation of abiraterone acetate.

INOVIO a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced that Dr. Joseph Kim, President and CEO, is scheduled to participate in a fireside chat and 1x1 investor meetings at the Jefferies 2021 Virtual Healthcare Conference on Tuesday, June 1, 2021 at 2:00 PM EDT.